Clinical Trial Update: ER Reactivation Therapy for Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of an ER reactivation therapy for metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED